Menu

Advent Technologies Holdings, Inc. (ADN)

—
$3.33
-0.06 (-1.92%)
Market Cap

$8.9M

P/E Ratio

N/A

Div Yield

0.00%

52W Range

$1.72 - $7.61

Company Profile

At a glance

• Strategic Transformation: Advent Technologies (NASDAQ:ADN) is undergoing a radical business model shift, moving away from capital-intensive, low-margin fuel cell system sales to focus exclusively on high-temperature Membrane Electrode Assembly (MEA) innovation, intellectual property, and manufacturing scale, aiming for a high-margin, low-CapEx licensing model by 2026.

• Differentiated Technology: The core of Advent's thesis lies in its proprietary Ion Pair MEA technology, which promises a 2x increase in power density and 2x longer lifetime compared to previous state-of-the-art HT-PEM fuel cells, enabling significantly lower costs and superior performance in demanding applications like aviation, heavy-duty transport, and data centers.

• Critical Partnerships & Grants: The company's future hinges on strategic joint development agreements with global OEMs (Airbus (TICKER:EADSY), Hyundai Motor Company (TICKER:HYMTF), US DoD, and four other top automakers) and substantial non-dilutive grant funding, notably the $34.53 million RHyno Project from the EU Innovation Fund and the long-delayed €782.1 million Green HiPo project.

Price Chart

Loading chart...

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks